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Abstract
Study Objective—Validate the sensitivity and specificity of two age adjustment strategies for 
D-dimer values in identifying patients at risk for pulmonary embolism (PE) compared to 
traditional D-dimer cutoff value (500ng/mL) to decrease inappropriate computed tomography 
pulmonary angiography (CTPA) utilization.
Methods—This institutional review board-approved, HIPAA-compliant retrospective study 
included all adult emergency department (ED) patients evaluated for PE over a 32-month period 
(1/1/11–8/30/13). Only patients undergoing CTPA and D-dimer testing were included. We used a 
validated natural language processing algorithm to parse CTPA radiology reports and determine 
presence of acute PE. Outcome measures were sensitivity and specificity of two age-adjusted D-
dimer cutoffs compared to the traditional cutoff. We used chi-square tests with proportional 
analyses to assess differences in traditional and age-adjusted (age × 10 ng/mL) D-dimer cutoffs, 
adjusting both by decade and by year.
Results—A total 3,063 patients with suspected PE were evaluated by CTPA during the study 
period and 1,055 (34%) also received D-dimer testing. The specificity of age-adjusted D-dimer 
values was similar or higher for each age group studied compared to traditional cutoff, without 
significantly compromising sensitivity. Overall, had decade age-adjusted cutoffs been used, 37 
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CTPAs could have been avoided (19.6% of 189 patients aged >60 with Wells score ≤4); had 
yearly age-adjusted cutoffs been used, 52 CTPAs (18.2% of 286 patients aged >50 with Wells 
score ≤4) could have been avoided.
Conclusion—Each age-adjusted D-dimer cutoff strategy for the evaluation of PE was associated 
with increased specificity and statistically insignificant decreased sensitivity when compared to 
the traditional D-dimer cutoff value.
MeSH Keywords
Diagnostic Test; Pulmonary Embolism; D-dimer; Evidence-Based Practice
Introduction
Background
Validated evidence-based guidelines based on clinical criteria and D-dimer values have been 
established to guide clinicians to risk-stratify emergency department (ED) patients suspected 
to have pulmonary embolism (PE).(1,2) Patients with high clinical pretest probabilities of 
PE warrant advanced imaging tests regardless of D-dimer levels, and most decision 
guidelines forego D-dimer testing in these patients. Conversely, the high sensitivity and 
negative predictive value of D-dimer allow its utilization to rule out PE in low to moderate 
risk patients. Therefore, only patients with an elevated D-dimer level undergo further 
advanced imaging.
Unfortunately, D-dimer testing has low specificity, resulting in increasing false positive 
results as the prevalence of disease decreases. However, recent studies have indicated that 
D-dimer levels tend to increase with age, and that the traditional cutoff value (500 ng/mL) 
may be associated with even lower specificity in older patients with low clinical 
probabilities on risk stratification.(3–8) This decrease in specificity with advancing age may 
lead to an increased volume of unnecessary and expensive advanced imaging tests.
Some earlier studies examined the impact of age-adjustment of D-dimer cutoffs by decade 
(e.g., 600 ng/mL for patients aged 61–70, 700 ng/mL for patients aged 71–80) in order to 
improve specificity and decrease false positive results.(3) A recent European prospective 
study(8) has gone a step further, recommending stratifying patients over 50 years old with a 
yearly age-adjusted D-dimer cutoff value (specific age in years × 10 ng/mL, e.g., a 560 
ng/mL cutoff for a patient aged 56 years). While this study demonstrated that this strategy 
improves the specificity of D-dimer testing in aging populations, it may be associated with 
lower sensitivity and increased false negatives, and has not yet been validated in a U.S. 
population.
Importance
The use of D-dimer testing to risk stratify patients suspected of PE often leads to further 
diagnostic testing, including computed tomography pulmonary angiography (CTPA) 
imaging, ventilation/perfusion lung scan (V/Q), and pulmonary angiography. The use of an 
age-adjusted D-dimer cutoff may improve specificity while maintaining sensitivity, thereby 
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decreasing low utility CTPA utilization with resulting decreases in costs, patient radiation 
exposure, and risk of contrast nephropathy.(3–8)
Goals of this Investigation
We aimed to validate the sensitivity of higher, decade and yearly age-adjusted, D-dimer 
value cutoffs for the identification of patients at low risk for PE. We hypothesized that using 
either age-adjusted cutoff for D-dimer values in comparison to the traditional cutoff would 
allow for less CTPA imaging while not lowering the test’s sensitivity for diagnosing PE. We 
further hypothesized that the yearly age-adjusted cutoff would lead to a higher specificity 
than the decade age-adjusted cutoff.
Materials and Methods
Study Setting
This retrospective study was performed in our adult ED, located in a 793-bed, urban, 
academic, quaternary, Level-1 trauma center. The requirement to obtain informed consent 
was waived by the institutional review board for this HIPAA-compliant study. The 
hospital’s laboratory utilizes the STA-Liatest quantitative D-dimer latex-based automated 
assays with immunoturbidimetric readings, providing a traditional dichotomous cutoff value 
of 500 ng/mL.
Selection of Participants
From January 1, 2011 to August 30, 2013, consecutive adult patients presenting to our ED 
undergoing evaluation for potential PE with recorded D-dimer laboratory values and CTPA 
results were identified in our electronic health record (EHR). Patients in whom CTPA was 
not part of the workup (i.e., who were evaluated via V/Q scan) were not included, as the 
frequency of CTPA-alternative testing is low at our institution.
Study Design
We first stratified all patients over 60 years old with an age-adjusted D-dimer cutoff value 
(age in years × 10 ng/mL) using decade cohorts (e.g., 600 ng/mL cutoff for 61–70 years old, 
700 ng/mL cutoff for 71–80 years old, etc.).(3) We then stratified patients over 50 years old 
with a yearly age-adjusted D-dimer cutoff value (specific age in years × 10 ng/mL, e.g., 560 
ng/mL cutoff for a patient aged 56 years).(8) We applied both age-adjusted D-dimer 
strategies to all patients who received CTPA in our retrospective cohort to maximize 
generalizability.
Outcome Measures
The primary outcome measure was sensitivity of age-adjusted D-dimer laboratory testing in 
risk stratifying patients with suspected PE in comparison to the traditional cutoff. Our 
secondary outcome was specificity of age-adjusted D-dimer testing in comparison to the 
traditional cutoff.
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Methods of Measurement
We used natural language processing (NLP) algorithms based on the GATE (General 
Architecture for Text Engineering) framework to parse all the CTPA radiology reports to 
determine presence of acute PE. The NLP model has been previously validated with 
accuracy of 97.8% compared to manual review.(9) All positive findings identified by NLP 
were further verified manually by an attending emergency physician (AG) by reviewing the 
radiology reports.
A board-certified emergency physician (AG) reviewed the EHR and data from a mandatory 
clinical decision support (CDS) tool(9,10) to determine Wells scores. All imaging orders in 
our ED are placed via computerized physician order entry (CPOE) system (Percipio, 
Medicalis Co, San Francisco, CA) with implementation described previously.(11) Our 
CPOE has an integrated CDS tool to prospectively capture granular data in the form of D-
dimer and individual Wells score criteria entered by the ordering clinician to provide 
evidence-based decision support as to the appropriateness of CTPA for evaluation of PE; 
implementation has been described previously.(9) The validity of data input into the CPOE 
and CDS systems for PE has also been previously reported.(12)
Data Analysis
All data were entered into Microsoft Excel 2008 (Microsoft, Richmond, WA), and all 
statistical analyses were performed with JMP Pro 10 (SAS Institute, Cary, NC). The sample 
size was powered to detect a 2% effect size (power=0.8, alpha=0.05) with an estimated 
baseline sensitivity of 99%. This resulted in a desired sample size of 223 records for the 
primary outcome. Chi-square tests with proportional analyses were used to assess 
differences in traditional and age-adjusted D-dimer laboratory cutoffs. We used the 
Newcombe score method with continuity correction for 95% confidence intervals around 
estimated proportions.(13) A two-tailed p-value of <0.05 was defined as statistically 
significant.
Results
Characteristics of Study Subjects
A total of 3,063 patient-visits with suspected PE were evaluated by CTPA during the study 
period with an overall yield of 9.4% (289 positive studies). In 1,055 (34%) patients, D-dimer 
values were also obtained and these patients were included in the study cohort. Of the 1,055 
patients, 729 (69.1%) were women, the mean age was 52.8 years (min 18, max 96, 95% CI 
51.7–53.9), and the median documented Wells score was 4.5 (min 0, max 12.5, 95% CI 3.9–
4.2). The prevalence of PE ranged from 5.8% in patients aged less than 50 years, to 10.1% 
in patients aged 61–70 (Table 4).
Main Results
The overall population sensitivity and specificity for PE using the traditional D-dimer cutoff 
value of 500 ng/mL were 100% (95% CI: 94.2–100%) and 7.4% (95% CI: 5.8–9.2%) (Table 
1). The population sensitivity and specificity for PE using the decade age-adjusted D-dimer 
cutoff values were 98.7% (95% CI: 92.1–99.9%) and 13.5% (95% CI: 12.2–16.8%) (Table 
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2). The population sensitivity and specificity for PE using the yearly age-adjusted D-dimer 
cutoff values were 97.4% (95% CI: 90.2–99.6%) and 16.7% (95% CI: 14.4–19.2%) (Table 
3).
The specificity of D-dimer testing with a traditional cutoff decreased with increasing age, 
from 10.5% in patients aged 51–60 years to 2.9% in patients aged more than 80 years (Table 
4). The sensitivities remained constant for all decades at 100%.
The use of the decade age-adjusted cutoff value significantly increased specificity of D-
dimer testing in all age groups, from 17.4% in patients aged 61–70 to 24.3% in patients aged 
more than 80 years (Table 4). The sensitivities also remained at 100% except for a single 
patient case in the >80 years group that reduced sensitivity to 85.7%.
The use of the yearly age-adjusted D-dimer cutoff value significantly increased specificity 
of D-dimer testing in all age groups, from 18.9% in patients aged 51–60 to 32.3% in patients 
aged more than 71–80 years (Table 4). The sensitivities also remained at 100% except for 
one 56 year-old patient in 51–60 year group who reduced sensitivity to 93.3% and one 87 
year-old patient in the >80 years group who reduced sensitivity to 85.7%. However, these 
sensitivity changes were not statistically different from the traditional cutoff strategy.
Overall, had decade age-adjusted cutoffs been used, 37 CTPAs (19.6% of 189 patients >60 
years old with Wells score ≤4) could have been avoided, as each of these patients had a D-
dimer value between 500 ng/mL and the respective decade cutoff. Had yearly age-adjusted 
cutoffs been used, 52 patients with Wells score ≤4 could have avoided CTPA, as their D-
dimer values were between 500 ng/mL and the respective yearly age-adjusted cutoff (18.2% 
of 286 patients >50 years old with Wells score ≤4).
Limitations
These data must be interpreted in the context of the study design. Our study was performed 
in a single academic setting utilizing the STA-Liatest immunoturbidimetric D-dimer assay. 
While this assay has been shown to have excellent sensitivity and specificity(14,15), the 
generalizability of our results is limited to institutions employing the same D-dimer assay. 
Nonetheless, the concept of age-adjusted D-dimers in evaluating PE should remain 
consistent across assays and has been shown previously.(15)
Our institution has CDS embedded within the CPOE system to provide evidence-based 
decision support to the ordering clinician as to the appropriateness of CTPA for evaluation 
of PE. Our implementation of CDS has previously shown decreases in utilization of CTPA, 
using traditional D-dimer cutoffs along with Wells score assessment.(9) While the setting of 
CDS may lower the generalizability of this study, its presence would likely underestimate 
the impact of the age-adjusted D-dimer cutoff strategies in further avoiding low utility 
CTPAs. Finally, in our cohort, 66% of patients with CTPA did not receive D-dimer testing. 
This likely reflects the current best practice of not obtaining D-dimer testing on patients in 
the “PE likely” subset of patients with Wells scores >4, which may have been larger at our 
site than in others due to our large oncology patient population. Further prospective studies 
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for high-risk patients may provide additional insight into the application of age-adjusted D-
dimer strategies in this patient population.
Discussion
We found that an age-adjusted D-dimer cutoff strategy in the evaluation of pulmonary 
embolus is associated with increased specificity while maintaining high sensitivity. This 
strategy increases the value of the D-dimer testing for the exclusion of PE in older patients.
Although D-dimers should only be applied to patients suspected of PE after assessment of 
pretest clinical probability (16,17), we applied the age-adjusted D-dimer strategies to all 
patients who received CTPA in our retrospective cohort to maximize generalizability.
We found that D-dimer specificity decreased with age when using the traditional D-dimer 
cutoff value, but that it significantly improved when using either the decade or yearly age-
adjusted D-dimer cutoff values. Sensitivity remained high for both strategies. Overall, had 
decade age-adjusted cutoffs been used, 37 CTPAs (19.6% of 189 patients >60 years old with 
Wells score ≤4) could have been avoided; had yearly age-adjusted cutoffs been used, 52 
patients (18.2% of 286 patients >50 years old with Wells score ≤4) could have avoided 
CTPA.
While a number of studies have evaluated the use of age-adjusting D-dimer cutoffs by 
patient decade, the strategy of using yearly age-adjusted cutoffs has not yet been extensively 
studied. Our results confirm those of the recent European study(8), which demonstrated that 
using yearly age-adjusted cutoffs would have resulted in 11.6% fewer CTPAs in their 
population. Their 3-month follow-up demonstrated only one missed PE in a patient with a 
D-dimer between 500 ng/mL and their age-adjusted cutoff.
Similarly, our cohort also included one patient who had a PE that was noted by the 
traditional D-dimer cutoff value, but missed by both the decade and yearly age-adjusted D-
dimer cutoff values. This patient was 87 years old with a D-dimer value of 598 ng/mL and a 
low pretest clinical probability for PE with a documented Wells score of 3. On review of his 
EHR, this patient was found to have a subsegmental PE, was admitted to the hospital, was 
not treated with anti-coagulation as the risk of therapy was deemed to be greater than the 
benefits by his clinicians, and was discharged without apparent complications. It might be 
argued that this patient had an incidental finding with no clinical impact, intervention, or 
morbidity. The treatment of subsegmental PE is a topic of debate. Some studies have found 
considerable interobserver variability amongst radiologists in the diagnosis of subsegmental 
PE versus perfusion artifact and a recent meta-analysis suggested “that subsegmental PE 
may not be clinically relevant.”(18)
Our cohort included a second patient who had a PE that was missed by the yearly age-
adjusted D-dimer cutoff only. This patient was 56 years old with a D-dimer value of 555 
ng/mL. On review of her EHR, this patient had a high pretest clinical probability for PE with 
a documented Wells score of 7.5. Following validated guidelines for the evaluation of 
patients suspected for PE, this patient warranted CTPA evaluation regardless of her D-dimer 
value.
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In summary, we found that implementation of yearly age-adjusted D-dimer cutoff for 
patients aged over 50 years suspected of PE would increase specificity with statistically 
insignificant reduction in sensitivity. This strategy may safely decrease the utilization of low 
utility CTPAs in patients >50 years old, resulting in increased patient protection from 
irradiation and the risk of contrast-induced nephropathy. Further, the yearly age-adjusted 
strategy may be simpler to calculate and may therefore be more likely to have widespread 
utilization in EDs compared to the decade strategy.
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Table 1
Pulmonary Embolism (PE) prevalence for all patients using traditional D-dimer cutoff values.
PE + PE − Total
D-dimer + 78 905 983
D-dimer − 0 72 72
Total 78 977 1055
Sensitivity = 100% (95% CI: 94.2–100%)
Specificity = 7.4% (95% CI: 5.8–9.2%)
Positive Predictive Value (PPV) = 7.9% (95% CI: 6.3–9.8%)
Negative Predictive Value (NPV) = 100% (95% CI: 93.7–100%)
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Table 2
PE prevalence for all patients using decade age-adjusted D-dimer cutoff values.
PE + PE − Total
D-dimer + 77 790 922
D-dimer − 1 132 133
Total 78 977 1055
Sensitivity = 98.7% (95% CI: 92.1–99.9%)
Specificity = 13.5% (95% CI: 12.2–16.8%)
PPV = 8.4% (95% CI: 7.1–11.0%)
NPV = 99.2% (95% CI: 99.2–99.9%)
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Table 3
PE prevalence for all patients using yearly age-adjusted D-dimer cutoff values.
PE + PE − Total
D-dimer + 76 814 890
D-dimer − 2 163 165
Total 78 977 1055
Sensitivity = 97.4% (95% CI: 90.2–99.6%)
Specificity = 16.7% (95% CI: 14.4–19.2%)
PPV = 8.5% (95% CI: 6.8–10.6%)
NPV = 98.8% (95% CI: 95.2–99.8%)
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)
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0
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0)
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%
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.5)
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(22
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.6)
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%
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.1–
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1%
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.0–
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.2)
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(42
.0–
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%
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.9)
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9%
(15
.2–
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.3)
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.5
7%
(18
.7–
40
.8)
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